Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Cambian’s dividend cheer

Behavioural health service provider Cambian (CMBN) is selling its adult business for £377m to American hospital management company Universal Health Services (UHS:NYSE)
This deal should return the business to rude health. Significantly, the proceeds will repay Cambian’s £293m of debt in full and still leave it with £40m to fund a 22p special payout and put it in a position to resume ordinary dividends.
The social care provider has agreed (5 Dec) to sell its adult services unit to Cygnet Health Care, part of Universal Health Services, for what looks like a good price.
Reflecting high levels of interest in the business, the proceeds represent an earnings multiple of 15.6 times. Crucially, the deal leaves Cambian, which previously ran into difficulties following some overly ambitious expansion, in ruder financial health and free to focus on rolling out its Children’s Services Business.
This offers significant opportunities for growth, development and the creation of shareholder value against a backdrop of growing demand for the critical services Cambian provides.
In addition to the special dividend, one implying a 16.1% yield at 136.75p, Cambian plans to resume its progressive dividend policy, with a payout likely to be declared around the time of the half year results in 2017.
Canaccord Genuity has upgraded its rating from ‘speculative buy’ to ‘buy’ and price target from 118p to 150p following the sale.
With operational issues behind it and this deal transforming the balance sheet, Cambian looks interesting again at 136.75p. (JC)
Important information:
These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell.
Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.
Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.